36C25022Q0216-07Jan2022.pdf
PDF 77 KB Posted
- Attached to
- COVID Sequencing Reagents Federal contract opportunity
- Solicitation number
- 36C25022Q0216
About this file
This notice announces a sole source contract award. The Department of Veterans Affairs intends to award a contract to Life Technology Corporation to provide COVID-19 sequencing reagents for use with Life Technology's Torrent Genexus sequencing instrument located at the Indianapolis VA Medical Center. The reagents are required to test COVID-19 variants and are unique to Life Technology's instrument. The contract value includes items such as SARS-CoV-2 assay panels, sequencing kits, chips, plates, seals, barcodes, and pipette tips. Responses from other sources will be accepted by the contracting officer until January 11, 2021 but award remains at the government's discretion.
View the file
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
The Department of Veterans Affairs, Network Contracting Office (NCO) 10, 260 E University Ave.
Cincinnati, OH 45219, intends to award a sole source purchase order contract to Life Technology
Corporation, 5781 Van Allen Way, Carlsbad, CA 92008 to provide VISN10 location Indianapolis VA
Medical Center, 1481 W 10th Street, Indianapolis, IN 46202-2803 COVID-19 Sequencing Reagents. Only one awardee can provide the supplies or services at the level of quality required because the supplies or services ordered are unique to Life Technology Corporation NAICS Code 334516. Analytical Laboratory
Instrument Manufacturing applies to this procurement. The Life Technology Corporation Torrent
Genexus sequencing instrument equipment is located at the Indianapolis VAMC. It is the only instrument that can sequence the variants for COVID-19 within our VISN and to other VAs that are assigned as their reference laboratory. This acquisition consists of procuring and delivery of patient
COVID-19 sequencing reagents for Life Technology Corporation’s instrument that meet and compliment to their software integrating with the existing instrument in use at the Indianapolis VA Medical Center.
The Life Technology Corporation laboratory equipment will test the sequence of variants for COVID-19 to include the following:
DESCRIPTION and ITEM NUMBER
A51307 SARS-COV-2 INSIGHT PANEL - GX 32 RXN
A40263 GXS TEMPL STRIPS 3-GX5 AND 4 COMBO
A40271 GENEXUS SEQUENCING KIT COMBO
A40269 ION GX5 CHIP AND GXS COUPLER KIT
4483354 96-WELL HARD-SHELL PLATE CLEAR
AB0626 ADHESIVE FOIL SEALS FOR MICROP LATES OR PCR PLATES
A40258 GENEXUS BARCODES 1-32 AS KIT
A40266 GENEXUS PIPETTE TIPS 12 RACK/96
This notice satisfies the requirement at FAR 5.201(b)(1), to publicize the proposed contract action. This notice of intent is not a request for competitive proposals or quotes. No solicitation documents are available; however, any firm that believes it that they can meet the requirements may give written notification to the Contracting Officer within 96 hours from the date of publication of this notice.
Supporting evidence must be furnished in enough detail to demonstrate compliance. Information must be sent electronically to dwight.petsche@va.gov. Any responses received will be evaluated; however, a determination by the Government as to whether to compete the proposed procurement based upon responses to this notice is solely within the discretion of the Government. Responses must be received within 96 hours of publication or by January 11, 2021 or whatever is sooner to be considered.
mailto:dwight.petsche@va.gov
File details come from the government source that posted it. Updated .